Results

Alnylam Pharmaceuticals Inc.

10/10/2019 | Press release | Distributed by Public on 10/10/2019 05:36

Alnylam Announces Filing for Marketing Authorization of ONPATTRO® (patisiran) in Brazil for the Treatment of Hereditary ATTR Amyloidosis with Polyneuropathy